BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2000

View Archived Issues

Patent covers charged tamoxifen derivatives for cancer therapy

Read More

Kinetek acquires Tyrogene, PTP platforms

Read More

BioQuest and BioKeys sign letter of intent

Read More

Curatek begins pivotal trial of clonidine gel for neuropathic pain

Read More

Liposomal PGE1 to enter phase III trials in critical limb ischemia

Read More

Orphan Medical updates Xyrem development and plans for NDA submission

Read More

AVI BioPharma accelerates development of platform technologies during 1999

Read More

NHLBI stops part of ALLHAT study prematurely, advises against first-line use of alpha-blockers

Read More

Regeneron and Emisphere establish collaboration for oral delivery of Axokine

Read More

The FDA approves Pacis immunotherapy for treatment of bladder cancer

Read More

Phase III trial of Anogesic as treatment for anal fissure pain commences

Read More

Amrad gets the go-ahead to move two new drugs into clinical testing

Read More

Alizyme reports successful completion of phase I trial for IBD therapy

Read More

Malignant melanoma antisense compound enters pivotal trials

Read More

AEterna cleared to commence phase III trial of AE-941 for treatment of kidney cancer

Read More

Connetics files IND for a phase II trial to evaluate ConXn in peripheral vascular disease

Read More

New anti-HIV agents produced by Streptomyces species

Read More

Japanese labs conduct joint research on squalene epoxidase inhibitors

Read More

Distamycin used as lead at P&U to design new alkylating agents

Read More

Suntory's new antiinflammatory agents act as inhibitors of NF-kB

Read More

Shionogi prepares chymase/cytokine inhibitors with beta-lactam structure

Read More

Triazolopyridine antiplatelet agents in the pipeline at Ortho-McNeil

Read More

Enteric-coated methylnaltrexone efficiently prevents GI effects of morphine in humans

Read More

Lipitor receives approval in Japan

Read More

EMLA cream useful as local anesthetic for epidural needle insertion, orotracheal intubation

Read More

Propofol derivative with different behavioral profile: effects on neurotransmitter release

Read More

BMS-193884 safely improves hemodynamics in heart failure patients; data presented to ACC

Read More

Preclinical, clinical studies on Sch-58235 presented at ACC meeting, support further investigations

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 11, 2026.
  • Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

    Cas and effect: Merck’s phase III ripples HIF-2α space

    BioWorld
    Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
  • Tanycytes in green capturing tau protein in red.

    Brain’s hidden tau-clearing pathway uncovered

    BioWorld Science
    Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing